ClinicalTrials.gg
CompletedNCT02344433VICKYUpdated Oct 24, 2019

Using Virtual Counselors to Overcome Genetic Literacy Barriers

An interventional study of VICKY and MFHP in Heart Disease, Stroke and Diabetes, sponsored by Boston University. Completed. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-24.

Sponsored by Boston University · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
279
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

A Relational Agent (RA) "virtual counselor" (VICKY: VIrtual Counselor for Knowing Your Family History) has been developed to collect family health history information for common health conditions including heart disease, stroke, diabetes, hypertension and various cancers. In this study, the investigators will conduct a randomized controlled trial (RCT) to compare the efficacy of using VICKY to the existing My Family Health Portrait (MFHP) tool for collecting family health history information among an underserved primary care patient population. The primary aims of the study are to 1) evaluate the efficacy of VICKY versus MFHP for collecting accurate family health histories and 2) determine whether accuracy varies as a function of health literacy. This project will obtain validation data on the efficacy of both VICKY and MFHP for collecting accurate family history data among an underserved patient population, in two languages (English and Spanish). The study will determine whether a virtual counselor can overcome many of the existing barriers to using traditional web-based family history tools.

02

Conditions studied

  • Heart Disease
  • Stroke
  • Diabetes
  • Cancer

Keywords

  • Family health history
  • Genetic literacy
  • Health literacy
  • Relational agent
  • Common chronic conditions
03

In context

Heart Diseases

3,674 studies on the registry are indexed under Heart Diseases; 458 are open to participants now.

This study's enrollment of 279 is above the median of 100 across 1,785 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Boston University is the lead sponsor of 270 studies on the registry; 38 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 24 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 21 years of age or older;
  • current Boston Medical Center patient - must have an upcoming returning patient appointment at Boston Medical Center or affiliated clinic within 3 months of recruitment;
  • speaks English and/or Spanish.

Exclusion criteria

Exclusion Criteria:

  • Under 21 years of age;
  • not a current patient of Boston Medical Center or affiliated clinic;
  • unable to speak English and/or Spanish.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
279 participants (actual)

Study arms

  • Experimental
    VICKY

    Relational agent, "virtual counselor" for collecting family health history (VICKY: VIrtual Counselor for Knowing Your Family History).

    Behavioral: VICKY

  • Active comparator
    MFHP

    Online family health history collection tool (MFHP: My Family Health Portrait).

    Behavioral: MFHP

Interventions

  • BehavioralVICKY

    Relational agent/virtual counselor

  • BehavioralMFHP

    US Surgeon General's family history tool

06

What researchers measure

Primary outcomes

  1. Accuracy of health conditions id'd (interview w/ genetic counselor gold standard. health conditions id'd by VICKY or MFHP id'd by genetic counselor (true +) divided by health conditions captured by genetic counselor (false - plus true +)

    Sensitivity will be calculated using an interview with a genetic counselor as the gold standard. Sensitivity will be defined as the health conditions identified by the family health history tool (VICKY or MFHP) that were also identified by the genetic counselor (true positive) divided by the health conditions not captured by the tool but captured by the genetic counselor (false negatives) plus the true positives.

    Time frame: Computed value derived from baseline assessments of family health history (both tool and counselor-obtained histories).

  2. Accuracy of family members identified (defined as the agreement of first and second degree relatives identified by both the tool (VICKY or MFHP) and the genetic counselor)

    Accuracy of family members identified will be defined as the agreement of first and second degree relatives identified by both the tool (VICKY or MFHP) and the genetic counselor.

    Time frame: Computed value derived from baseline assessments of family health history (both tool and counselor-obtained histories).

Secondary outcomes

  1. Family and provider communication (Communication of family health history with family members and health care providers)

    Communication of family health history with family members and health care providers.

    Time frame: Baseline and 3 month follow-up

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Wang C, Paasche-Orlow MK, Bowen DJ, Cabral H, Winter MR, Norkunas Cunningham T, Trevino-Talbot M, Toledo DM, Cortes DE, Campion M, Bickmore T. Utility of a virtual counselor (VICKY) to collect family health histories among vulnerable patient populations: A randomized controlled trial. Patient Educ Couns. 2021 May;104(5):979-988. doi: 10.1016/j.pec.2021.02.034. Epub 2021 Feb 18. PubMed 33750594 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 24, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02344433
Lead sponsor
Boston University
Collaborators
Northeastern University, National Human Genome Research Institute (NHGRI)
Responsible party
Catharine Wang (Associate Professor, Boston University) — Principal investigator
First posted
Jan 26, 2015
Start date
Nov 2016
Primary completion
Oct 2019
Completion
Oct 2019
Last update
Oct 24, 2019

Study contacts

Catharine Wang
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion